Previously banned drug becomes anti-cancer superhero
Cancer Multiple Myeloma Thalidomide

Previously banned drug becomes anti-cancer superhero

Dr Pratap Acharya
Dr Pratap Acharya

Recent studies support thalidomide’s use against blood cancers like multiple myeloma (MM) and suggest that the drug can help target cancer-promoting agents that were previously drug resistant. Additionally, it produced better survival rates in MM patients than other drugs in a recent trial.

In 10 seconds? Thalidomide, notorious for birth defects in the 1960s is now routinely used to treat multiple myeloma, but researchers have discovered more of its hidden powers that can help target other cancers.

Get unlimited access to our 3-min Digests and other premium features

Choose your plan:

Personal

$99/year

✅ Includes 7-day free trial for new users
✅ Weekly Recap
✅ Daily newsletter
✅ Access 4 topic areas of your choosing
✅ Access all citations and resources
✅ Gain background knowledge with a Quick Dive
✅ The Sparrow Sessions Podcast
✅ No ads
❌ Direct access to the Expert Network
❌ Your questions - answered by an Expert Scientist
❌ 12 hours of consultations with our fabulous experts per year (that’s 1 hour per month!)
❌ Access to all topic areas as we scale the Content Library

We'll send you a reminder email 3 days before your trial ends.

Start my free trial

Professional

$3499/year

✅ Includes 7-day free trial for new users
✅ Weekly Recap
✅ Daily newsletter
✅ Access all citations and resources
✅ Gain background knowledge with a Quick Dive
✅ The Sparrow Sessions Podcast
✅ No ads
✅ Direct access to the Expert Network
✅ Your questions - answered by an Expert Scientist
✅ 12 hours of consultations with our fabulous experts per year (that’s 1 hour per month!)
✅ Access to all topic areas as we scale the Content Library

We'll send you a reminder email 3 days before your trial ends.

Start my free trial